Wilmington, NC, United States of America

Arthur J Spivack

This inventor holds 1 USPTO granted patent. Top assignee: Applied Semiconductor, Inc.. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arthur J Spivack: Innovator in Biomedical Device Protection

Introduction

Arthur J Spivack is a notable inventor based in Wilmington, NC (US). He has made significant contributions to the field of biomedical devices, particularly in preventing fouling and corrosion. His innovative approach has led to the development of a patented method that enhances the longevity and functionality of these critical devices.

Latest Patents

Arthur J Spivack holds a patent for a "Method and system of preventing fouling and corrosion of biomedical devices and structures." This patent addresses a crucial issue in the biomedical field, ensuring that devices remain effective and safe for use over time. His work in this area is vital for improving patient outcomes and device reliability.

Career Highlights

Spivack is currently associated with Applied Semiconductor, Inc., where he continues to work on advancements in semiconductor technology and biomedical applications. His career reflects a commitment to innovation and excellence in engineering.

Collaborations

Throughout his career, Arthur has collaborated with esteemed colleagues such as Joseph Bonaventura and Louis Ignarro. These partnerships have fostered a creative environment that encourages the development of groundbreaking solutions in biomedical technology.

Conclusion

Arthur J Spivack's contributions to the field of biomedical devices through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to influence the industry positively, ensuring better performance and safety in medical applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…